Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Chemoradiation in NSCLC: focus on the role of gemcitabine.
Hak Choy
Radiation Oncology
Radiation Oncology - Administration
Research output
:
Contribution to journal
›
Review article
›
peer-review
8
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Chemoradiation in NSCLC: focus on the role of gemcitabine.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
gemcitabine
100%
Radiotherapy
35%
Chemoradiotherapy
27%
Radiation-Sensitizing Agents
18%
Cisplatin
11%
Non-Small Cell Lung Carcinoma
11%
Clinical Trials
8%
Drug Therapy
7%
Safety
7%
Pharmaceutical Preparations
5%
Neoplasms
4%
Therapeutics
2%